Psyence Biomedical PBM
NASDAQ PBM
$3.94 +0.01 (+0.38%)
As of: Aug 21, 2026 · 9:34 AM EDT

Psyence Biomedical Ltd. (PBM) Receivables - Other (2023 - 2026)

Psyence Biomedical (PBM) posted quarterly Receivables - Other of $109779.0 for Q1 2026, down 20.07% year-over-year from $137348.0 in Q1 2025, and down 36.98% quarter-over-quarter from $174187.0 in Q3 2025.

Psyence Biomedical Ltd. (PBM) Receivables - Other (2023 - 2026) Analysis & Trends

Psyence Biomedical's Receivables - Other history runs 4 years deep, the most recent figure standing at $109779.0 for Q1 2026.

  • In Q1 2026, Receivables - Other fell 20.07% year-over-year to $109779.0; the TTM figure through Mar 2026 stood at $109779.0 (down 20.07% YoY), while the FY2026 annual figure was $109779.0, down 20.07% from the prior year.
  • Receivables - Other for Q1 2026 stood at $109779.0, down from $174187.0 in the prior quarter.
  • The five-year high for Receivables - Other was $174187.0 in Q3 2025, with the low at $41747.0 in Q1 2024.
  • The 4-year median for Receivables - Other is $131214.0 (2024), against an average of $122918.3.
  • The sharpest annual moves came in 2024 and 2025: Receivables - Other sank 72.05% in 2024, then surged 229.0% in 2025.
  • Psyence Biomedical's Receivables - Other stood at $149369.0 in 2023, then slipped by 16.26% to $125080.0 in 2024, then soared by 39.26% to $174187.0 in 2025, then tumbled by 36.98% to $109779.0 in 2026.
  • Business Quant data shows PBM's Receivables - Other at $109779.0 in Q1 2026, $174187.0 in Q3 2025, and $137348.0 in Q1 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Mar 31, 2026 109,779.00
Mar 31, 2026 109,779.00
Sep 30, 2025 174,187.00
Sep 30, 2025 174,187.00
Mar 31, 2025 137,348.00
Mar 31, 2025 137,348.00
Sep 30, 2024 125,080.00
Sep 30, 2024 125,080.00
Mar 31, 2024 41,747.00
Mar 31, 2024 41,747.00
Mar 31, 2023 149,369.00
Mar 31, 2023 149,369.00